GIRFT has worked with leading clinicians, supported by NHS Blood and Transplant, and the relevant Royal Colleges, to support the development of a Commissioning for Quality and Innovation (CQUIN) scheme specification for pre-operative management of anaemia.
The CQUIN scheme specification is intended to support improved identification and treatment of iron deficient anaemia for patients undergoing major elective blood loss surgery.
Identifying anaemia with a blood test and providing patients with iron treatment is known to reduce the risks associated with blood transfusion and help patients return home sooner after surgery. These benefits to patients also help make NHS services more efficient and cost-effective.
CQUIN CCG10: Screening and treatment of iron deficiency anaemia in patients listed for major elective blood loss surgery aims to achieve this, building on existing NICE guidance and clinical audit work by NHS Blood and Transplant.
GIRFT is supporting the development of this CQUIN, ahead of publication of the GIRFT national report on anaesthesia and perioperative medicine, as part of efforts to reduce unwarranted variation.